Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Zeo ScientifiX's Enterprise Value is $12.21 Mil.
Zeo ScientifiX's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was $-3.81 Mil. Therefore, Zeo ScientifiX's EV-to-EBIT ratio for today is -3.21.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Zeo ScientifiX's Enterprise Value is $12.21 Mil.
Zeo ScientifiX's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was $-3.73 Mil. Therefore, Zeo ScientifiX's EV-to-EBITDA ratio for today is -3.27.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Zeo ScientifiX's Enterprise Value is $12.21 Mil.
Zeo ScientifiX's Revenue for the trailing twelve months (TTM) ended in Apr. 2026 was $6.99 Mil. Therefore, Zeo ScientifiX's EV-to-Revenue ratio for today is 1.75.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Zeo ScientifiX's Enterprise Value is $12.21 Mil.
Zeo ScientifiX's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $-1.33 Mil. Therefore, Zeo ScientifiX's EV-to-FCF ratio for today is -9.20.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Zeo ScientifiX (OTCPK:ZEOX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Zeo ScientifiX's current Enterprise Value is $12.21 Mil.
Zeo ScientifiX's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.81 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Zeo ScientifiX's current Enterprise Value is $12.21 Mil.
Zeo ScientifiX's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.73 Mil.
Zeo ScientifiX's current Enterprise Value is $12.21 Mil.
Zeo ScientifiX's Revenue for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.99 Mil.
Zeo ScientifiX's current Enterprise Value is $12.21 Mil.
Zeo ScientifiX's Cash Flow from Operations for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.25 Mil.
Zeo ScientifiX's current Enterprise Value is $12.21 Mil.
Zeo ScientifiX's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX Enterprise Value Related Terms
Zeo ScientifiX Enterprise Value Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZEOX vs LNAI, GDTC, HOOK: Enterprise Value Comparison
For the Biotechnology subindustry, Zeo ScientifiX's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Zeo ScientifiX's Enterprise Value for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (ZEOX) has a Enterprise Value of $12.21 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Zeo ScientifiX and its competitors.
Is Zeo ScientifiX's Enterprise Value too high?
Zeo ScientifiX's current Enterprise Value is $12.21 Mil. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Enterprise Value compare to LNAI and GDTC?
Zeo ScientifiX's Enterprise Value of $12.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current Enterprise Value is $12.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current Enterprise Value is $12.21 Mil. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Enterprise Value is $12.21 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
Enterprise Value: $12.21 Mil
GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
50GF Score
Get the complete analysis for ZEOX
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
